Stiles Brendon M, Altorki Nasser K
Division of Thoracic Surgery, Department of Cardiothoracic Surgery, Weill Cornell Medical College, Suite M404, 525 East 68th Street, New York, NY 10021, USA.
Surg Oncol Clin N Am. 2011 Oct;20(4):619-35. doi: 10.1016/j.soc.2011.07.001.
Lung cancer is a global health burden and is among the most common and deadly of all malignancies worldwide. Early detection of resectable and potentially curable disease may reduce the overall death rate from lung cancer. However, at the present time, screening for lung cancer is not recommended by most clinical societies and health care agencies in the United States. This article discusses the history of, and rationale for, lung cancer screening, addresses optimization of screening protocols, and describes our current approach for the evaluation of small pulmonary nodules referred for surgical management.
肺癌是一项全球性的健康负担，是全球所有恶性肿瘤中最常见且致命的疾病之一。早期检测出可切除且可能治愈的疾病或许能降低肺癌的总体死亡率。然而，目前美国大多数临床学会和医疗保健机构并不推荐进行肺癌筛查。本文探讨了肺癌筛查的历史及理论依据，论述了筛查方案的优化，并描述了我们目前对转诊至外科治疗的肺部小结节进行评估的方法。
